Realize the Potential of Genomic Data in Drug Development
Ovation offers a consented biobank of ~1.57 million samples that can be sequenced to generate genomic data across more than 60 pre-defined disease cohorts
Consented samples (Sample types include FFPE tissue, nasopharyngeal swabs, preserved saliva, whole blood, total nucleic, and more)
Unique Patients
Tissue Samples
New Samples per Month
Pre-defined disease cohorts
Samples are sequenced to deliver:
- Whole genome sequencing (30X Depth)
- Whole exome sequencing
- mRNA and RNA sequencing
- And more sample types include FFPE tissue, nasopharyngeal swabs, preserved saliva, whole blood and total nucleic acid
Cohorts are developed through linkage to phenotypic data using common tokens.
Phenotypic and clinical data including treatment exposure, comorbidities, lab value and disease severity metrics from top claims and/or EHR vendors is linked to genomic data from Ovation’s database.
Let’s work together to advance
science forward
Our team combines the best of the tech and biotech worlds with vast experience managing large clinical and genomic data sets. Our delivery teams and clinical affairs specialists work together to deliver the highest quality data.
Explore more about
Ovation’s Data Products
Webinar
Linking Genomic and Phenotypic Data to Understand the Patient Journey
Data in Action
Realizing the Value of Biospecimens for Life Sciences Research in IBD
Thought Leadership
Ovation Presents at the 2023 AWS Life Sciences Executive Symposium